Swiss Bridge: Young Investigator Award for Immunotherapy in Oncology (LOI)

Supports young investigators (under 45) with projects focusing on immune cell therapy: chimeric antigen receptor T-cell (CAR T-cell) therapy, tumor-infiltrating lymphocytes (TILs) therapy, and dendritic cell vaccine therapy.

Funding: up to CHF 300K over 3 years.

No overhead - Please contact the research authority.

http://www.swissbridge.ch/call-for-application.html